“…Second, as we focus on the disease natural history of small breast cancers rather than all breast cancers, large samples are, therefore, required if these new phenotypes are further considered. In a similar manner, the current study is also limited to allow for the incorporation of new mammographic techniques and alternative imaging techniques, which have also been tested as screening tools, such as tomosynthesis [ 29 , 30 , 31 , 32 , 33 ], contrast enhanced spectral mammography (CESM) [ 34 , 35 ], magnetic resonance imaging (MRI) [ 36 , 37 ], ultrasound [ 37 , 38 ] and also fully automated support systems and AI systems [ 39 , 40 ]. In spite of the lack of such information, we believe the expedient use of fully automated systems such as computer-aided systems may yield sensitivity as favorable as that operated by the top radiologist (Tabar Laszlo), one of the co-authors, in the second period when such a fully automated system is still immature.…”